Stopping & maintenance
How long can you stay on a GLP-1?
October 2, 2026 · 6 min read · Medically reviewed by Bryan Milton, MD · Reviewed October 2, 2026
The labels set no time limit, and the long-term evidence is still accumulating. What is known, what is not, and what to review with your clinician over time.
There is no stop date on the label. These medications are approved for chronic conditions and are used as long-term treatments, which means the duration question is answered by review rather than by a rule.
What do the labels say about duration?
They do not set a maximum. The approved products are indicated for conditions understood as chronic — type 2 diabetes, chronic weight management, and in some cases cardiovascular risk reduction or obstructive sleep apnea. Chronic conditions are treated on an ongoing basis, and the labels are written accordingly.
How long has it been studied?
The pivotal trials ran over periods measured in months to a couple of years, with extension studies and post-marketing experience adding more. That is a substantial evidence base by the standards of a relatively new class, and it is also finite: evidence about use over much longer horizons is still accumulating, as it is for any medication of this age.
What that means in practice is not alarming, and it is worth being clear-eyed about: nobody can show you a decade of randomised data, because it does not exist yet.
Why duration is a real question
The published trials of the FDA-approved products measured what happened while people were taking them. The withdrawal and extension studies that followed indicate the effects are tied to continued treatment rather than persisting after it — which is the single most important thing to understand before starting, not after.
So the choice is not between treating for a while and being cured. It is between continuing, continuing at a lower dose, or stopping and managing what follows. That is the actual decision, and it is better made explicitly.
| Review | Why |
|---|---|
| Is it still working? | The reason for continuing has to still apply |
| Is it still tolerated? | Side effects can appear or change later in treatment |
| Is the dose still right? | The lowest effective dose may be lower than it was |
| Has anything changed? | New conditions, medications, or pregnancy plans |
| What is the plan? | Continue, reduce, maintain lower, or stop — decided, not drifted into |
What would make a clinician stop it?
- A serious adverse reaction, or a contraindication that develops.
- Pregnancy, or planning a pregnancy — these medications are not for use in pregnancy.
- It not working, after a fair trial at an appropriate dose.
- A change in what is being treated, making it no longer indicated.
- Your decision, which is legitimate and should be discussed rather than enacted silently.
Does this differ for a compounded preparation?
The molecule and its evidence base are the same. What differs is the preparation: Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Long-term use of a compounded preparation also depends on the regulatory position for compounding, which has shifted more than once — a reason to keep the conversation with your prescriber current rather than assume continuity.
This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.